PAHC
Phibro Animal Health Corporation
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Neutral
-2/100
Last price
36.61
▼ 0.58 (1.56%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
37.46
Prev close
37.19
Day high
37.70
Day low
36.32
Volume
133.23K
Market cap
$1.49B
P/E (TTM)
15.32
52W range
28.25 – 60.08
Day trading desk
Gap from prior close
+0.73%
Prior close 37.19
VWAP
36.69
-0.23% from price
Relative volume
0.94×
Normal
Session range
3.80%
36.32 – 37.70
Position in range
21%
Near session low
ATR (14D)
1.27
3.47% of price
Prior day high
38.05
PDH
Prior day low
37.05
PDL
Bid / ask spread
—
Quote not published
Session volume
223.29K
Avg 238.03K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.27%
+1.3%
1M
-4.29%
-5.4%
3M
+12.85%
+8.3%
6M
-34.23%
-52.4%
YTD
-2.01%
-16.3%
1Y
-4.46%
-20.9%
3Y
+186.69%
+104.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PAHC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+66.93K
Net buying
Buy transactions
10
148.90K shares
Sell transactions
4
81.97K shares
Net transactions
+14
Buys less sells
Sell : buy shares
0.6 : 1
Mixed
Insider-held shares
352.42K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 6, 26 | BENDHEIM JACK C Officer, Director and Beneficial Owner |
STOCK | 12.10K | $0 | Direct |
| Aug 6, 26 | MILLER LARRY LEE Chief Operating Officer |
STOCK | 3.52K | $0 | Direct |
| Aug 6, 26 | BENDHEIM DANIEL M Chief Executive Officer |
STOCK | 11.70K | $0 | Direct |
| Aug 6, 26 | DAVID GLENN C Chief Financial Officer |
STOCK | 3.33K | $0 | Direct |
| Aug 6, 26 | ESCUDERO LISA ANN Officer |
STOCK | 1.55K | $0 | Direct |
| Aug 6, 26 | BENDHEIM JONATHAN Director |
STOCK | 2.72K | $0 | Direct |
| Aug 6, 26 | WEINSTEIN JUDITH General Counsel |
STOCK | 2.48K | $0 | Direct |
| Aug 6, 26 | RODRIGUEZ PATRICK Officer and Treasurer |
STOCK | 1.50K | $0 | Direct |
| May 29, 26 | CORCORAN E. THOMAS Director |
BUY | 10.00K | $317.70K | Direct |
| May 7, 26 | BENDHEIM JACK C Chief Executive Officer |
SELL | 18.61K | $1.02M | Indirect |
| Apr 30, 26 | BENDHEIM JACK CLIFFORD Chief Executive Officer |
SELL | 21.12K | $1.14M | Indirect |
| Apr 23, 26 | BENDHEIM JACK C Chief Executive Officer |
SELL | 21.12K | $1.16M | Indirect |
| Apr 16, 26 | BENDHEIM JACK C Chief Executive Officer |
SELL | 21.12K | $1.20M | Indirect |
| Apr 16, 26 | BENDHEIM JACK C Chief Executive Officer |
— | 100.00K | — | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANDOLINO ANTHONY |
Officer and Treasurer | 1.79K | Stock Award(Grant) |
BENDHEIM DANIEL M |
Chief Executive Officer | 15.18K | Stock Award(Grant) |
BENDHEIM JACK C |
Officer, Director and Beneficial Owner | 82.79K | Stock Award(Grant) |
BENDHEIM JACK CLIFFORD |
Chief Executive Officer | — | Sale |
BENDHEIM JONATHAN |
Director | 5.98K | Stock Award(Grant) |
CORCORAN E. THOMAS |
Director | 41.46K | Purchase |
DAVID GLENN C |
Chief Financial Officer | 54.81K | Stock Award(Grant) |
ESCUDERO LISA ANN |
Officer | 3.43K | Stock Award(Grant) |
MILLER LARRY LEE |
Chief Operating Officer | 38.07K | Stock Award(Grant) |
WEINSTEIN JUDITH |
General Counsel | 5.45K | Stock Award(Grant) |
Fundamentals
Market cap$1.49B
Enterprise value$2.20B
Revenue (TTM)$1.52B
Gross profit$505.97M
EBITDA$244.23M
Net income$99.72M
EPS (TTM)$2.39
Free cash flow$-19.30M
Total cash$83.98M
Total debt$795.65M
Book value / share$9.50
Shares outstanding21.11M
Float20.91M
Short % of float6.43%
Dividend yield1.31%
Beta (5Y)0.42
Valuation & profitability ratios
Trailing P/E15.32
Forward P/E9.53
PEG ratio1.68
Price / sales—
Price / book3.85
EV / revenue1.45
EV / EBITDA9.00
Gross margin33.33%
Operating margin10.64%
Profit margin6.57%
Return on equity29.72%
Return on assets8.48%
Debt / equity206.41
Current ratio2.96
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.52B | $1.30B | $1.02B | $977.89M | +17.1% |
| Operating revenue | $1.52B | $1.30B | $1.02B | $977.89M | +17.1% |
| Cost of revenue | $1.01B | $896.27M | $704.59M | $679.65M | +12.2% |
| Gross profit | $512.51M | $399.94M | $313.09M | $298.24M | +28.1% |
| Selling, general & admin | $318.12M | $289.48M | $259.78M | $226.39M | +9.9% |
| Total operating expense | $318.12M | $289.48M | $259.78M | $226.39M | +9.9% |
| Operating income | $194.40M | $110.47M | $53.31M | $71.85M | +76.0% |
| Net interest income | -$44.43M | -$34.60M | -$18.54M | -$15.32M | -28.4% |
| Pre-tax income | $137.35M | $67.99M | $10.92M | $54.07M | +102.0% |
| Tax provision | $37.63M | $19.73M | $8.50M | $21.46M | +90.7% |
| Net income | $99.72M | $48.26M | $2.42M | $32.61M | +106.6% |
| Net income to common | $99.72M | $48.26M | $2.42M | $32.61M | +106.6% |
| Basic EPS | 2.46 | 1.19 | 0.06 | 0.81 | +106.7% |
| Diluted EPS | 2.43 | 1.19 | 0.06 | 0.81 | +104.2% |
| EBIT | $181.44M | $101.24M | $32.89M | $72.02M | +79.2% |
| EBITDA | $232.96M | $146.85M | $69.06M | $106.03M | +58.6% |
| Basic shares | 40.55M | 40.52M | 40.50M | 40.50M | +0.1% |
| Diluted shares | 40.96M | 40.68M | 40.52M | 40.50M | +0.7% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $61.42M | $68.04M | $70.61M | $41.28M | -9.7% |
| Cash & short-term investments | $81.99M | $77.04M | $114.61M | $81.28M | +6.4% |
| Accounts receivable | $238.79M | $227.98M | $169.45M | $163.48M | +4.7% |
| Inventory | $534.88M | $444.43M | $265.91M | $277.57M | +20.4% |
| Total current assets | $935.51M | $810.61M | $601.00M | $585.72M | +15.4% |
| Property, plant & equipment | $420.75M | $396.03M | $240.90M | $231.33M | +6.2% |
| Goodwill & intangibles | $90.10M | $96.11M | $99.59M | $108.26M | -6.3% |
| Total assets | $1.50B | $1.36B | $982.18M | $971.40M | +10.3% |
| Total current liabilities | $316.47M | $293.47M | $204.15M | $176.00M | +7.8% |
| Current debt | $25.02M | $16.25M | $29.80M | $22.30M | +54.0% |
| Long-term debt | $707.77M | $702.43M | $458.29M | $452.54M | +0.8% |
| Total debt | $788.77M | $761.55M | $525.46M | $509.97M | +3.6% |
| Total liabilities | $1.12B | $1.08B | $725.54M | $688.89M | +3.8% |
| Retained earnings | $352.96M | $272.70M | $243.89M | $260.91M | +29.4% |
| Shareholder equity | $385.48M | $285.68M | $256.64M | $282.51M | +34.9% |
| Working capital | $619.04M | $517.13M | $396.85M | $409.72M | +19.7% |
| Net tangible assets | $295.38M | $189.57M | $157.05M | $174.25M | +55.8% |
| Shares issued | 40.56M | 40.53M | 40.50M | 40.50M | +0.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $99.72M | $48.26M | $2.42M | $32.61M | +106.6% |
| Depreciation & amortisation | $51.51M | $45.60M | $36.18M | $34.01M | +13.0% |
| Stock-based compensation | $1.60M | $717.00K | $475.00K | $0 | +122.7% |
| Change in working capital | -$95.10M | -$21.56M | $33.11M | -$41.13M | -341.0% |
| Operating cash flow | $68.95M | $80.12M | $87.59M | $13.31M | -13.9% |
| Capital expenditure | -$59.09M | -$38.29M | -$41.24M | -$51.79M | -54.3% |
| Investing cash flow | -$71.45M | -$288.69M | -$48.19M | -$74.02M | +75.2% |
| Dividends paid | -$19.46M | -$19.45M | -$19.44M | -$19.44M | -0.1% |
| Financing cash flow | -$6.56M | $207.13M | -$6.77M | $26.99M | -103.2% |
| Free cash flow | $9.87M | $41.83M | $46.36M | -$38.48M | -76.4% |
| End cash position | $61.42M | $68.04M | $70.61M | $41.28M | -9.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $396.75M | $383.54M | $373.91M | $363.89M | $378.70M | +3.4% |
| Operating revenue | $396.75M | $383.54M | $373.91M | $363.89M | $378.70M | +3.4% |
| Cost of revenue | $262.35M | $257.87M | $241.25M | $244.11M | $268.69M | +1.7% |
| Gross profit | $134.40M | $125.67M | $132.66M | $119.78M | $110.01M | +6.9% |
| Selling, general & admin | $86.24M | $81.02M | $82.33M | $68.52M | $76.29M | +6.4% |
| Total operating expense | $86.24M | $81.02M | $82.33M | $68.52M | $76.29M | +6.4% |
| Operating income | $48.16M | $44.65M | $50.33M | $51.26M | $33.72M | +7.8% |
| Net interest income | -$10.18M | -$10.43M | -$11.76M | -$12.06M | -$8.61M | +2.4% |
| Pre-tax income | $32.34M | $32.31M | $36.42M | $36.27M | $23.85M | +0.1% |
| Tax provision | $10.63M | $8.29M | $8.97M | $9.74M | $6.62M | +28.3% |
| Net income | $21.71M | $24.02M | $27.46M | $26.53M | $17.22M | -9.6% |
| Net income to common | $21.71M | $24.02M | $27.46M | $26.53M | $17.22M | -9.6% |
| Basic EPS | 0.54 | 0.59 | 0.68 | 0.65 | 0.42 | -8.5% |
| Diluted EPS | 0.53 | 0.59 | 0.67 | 0.65 | 0.42 | -10.2% |
| EBIT | $42.45M | $42.42M | $48.27M | $48.24M | $32.30M | +0.1% |
| EBITDA | $55.80M | $54.87M | $61.16M | $61.07M | $44.71M | +1.7% |
| Basic shares | 40.60M | 40.55M | 40.53M | 40.53M | 40.50M | +0.1% |
| Diluted shares | 41.00M | 41.04M | 40.96M | 40.88M | 40.70M | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $61.42M | $54.93M | $55.49M | $72.77M | $68.04M | +11.8% |
| Cash & short-term investments | $81.99M | $77.45M | $74.51M | $85.27M | $77.04M | +5.9% |
| Accounts receivable | $238.79M | $221.55M | $215.87M | $217.90M | $227.98M | +7.8% |
| Inventory | $534.88M | $539.70M | $517.35M | $471.77M | $444.43M | -0.9% |
| Total current assets | $935.51M | $894.07M | $862.18M | $835.80M | $810.61M | +4.6% |
| Property, plant & equipment | $420.75M | $408.51M | $394.80M | $394.93M | $396.03M | +3.0% |
| Goodwill & intangibles | $90.10M | $91.57M | $92.88M | $94.67M | $96.11M | -1.6% |
| Total assets | $1.50B | $1.45B | $1.41B | $1.39B | $1.36B | +3.9% |
| Total current liabilities | $316.47M | $281.87M | $282.37M | $270.14M | $293.47M | +12.3% |
| Current debt | $25.02M | $22.83M | $20.64M | $18.44M | $16.25M | +9.6% |
| Long-term debt | $707.77M | $712.68M | $710.60M | $724.52M | $702.43M | -0.7% |
| Total debt | $788.77M | $787.44M | $773.17M | $785.10M | $761.55M | +0.2% |
| Total liabilities | $1.12B | $1.08B | $1.07B | $1.07B | $1.08B | +3.0% |
| Retained earnings | $352.96M | $336.12M | $316.96M | $294.36M | $272.70M | +5.0% |
| Shareholder equity | $385.48M | $361.83M | $332.36M | $311.68M | $285.68M | +6.5% |
| Working capital | $619.04M | $612.20M | $579.82M | $565.66M | $517.13M | +1.1% |
| Net tangible assets | $295.38M | $270.25M | $239.48M | $217.01M | $189.57M | +9.3% |
| Shares issued | 40.56M | 40.56M | 40.53M | 40.53M | 40.53M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $21.71M | $24.02M | $27.46M | $26.53M | $17.22M | -9.6% |
| Depreciation & amortisation | $13.35M | $12.45M | $12.89M | $12.83M | $12.41M | +7.2% |
| Stock-based compensation | $413.00K | $411.00K | $434.00K | $339.00K | $179.00K | +0.5% |
| Change in working capital | -$9.76M | -$26.71M | -$25.09M | -$33.54M | -$14.25M | +63.5% |
| Operating cash flow | $24.09M | $16.21M | $19.35M | $9.30M | $21.27M | +48.7% |
| Capital expenditure | -$18.87M | -$15.32M | -$11.10M | -$13.81M | -$13.14M | -23.2% |
| Investing cash flow | -$16.45M | -$16.81M | -$17.18M | -$21.01M | -$7.03M | +2.1% |
| Dividends paid | -$4.87M | -$4.87M | -$4.86M | -$4.86M | -$4.86M | +0.0% |
| Financing cash flow | -$1.61M | -$2.30M | -$18.98M | $16.34M | -$7.77M | +29.8% |
| Free cash flow | $5.22M | $890.00K | $8.26M | -$4.50M | $8.13M | +487.1% |
| End cash position | $61.42M | $54.93M | $55.49M | $72.77M | $68.04M | +11.8% |
Options analytics
Put / call volume
0.05
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
17.50
-52.2% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
-6.2%
Calls bid over puts
Call volume
19
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
30.00
0 contracts
Heaviest put OI
17.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.73 | 0.85 | +17.1% |
| Mar 2026 | 0.71 | 0.76 | +6.5% |
| Dec 2025 | 0.67 | 0.87 | +29.8% |
| Sep 2025 | 0.60 | 0.73 | +21.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.76 | 3 | $381.89M | +4.9% |
| Next quarter | 0.99 | 2 | $391.35M | +4.7% |
| Current year | 3.50 | 4 | $1.58B | +3.8% |
| Next year | 3.84 | 4 | $1.63B | +3.5% |
Analyst targets & ownership
Mean target$44.00
High target$55.00
Low target$35.00
Implied upside20.19%
Analyst count4
ConsensusHOLD
Strong buy / Buy1 / 0
Hold2
Sell / Strong sell0 / 1
Held by insiders0.87%
Held by institutions103.94%
Institutions holding308
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
35.63
+2.76% from price
SMA 20
35.52
+3.07% from price
SMA 50
35.88
+2.02% from price
SMA 100
34.24
+6.91% from price
SMA 200
41.28
-11.32% from price
EMA 12
35.99
+1.71% from price
EMA 26
35.83
+2.17% from price
EMA 50
35.80
+2.25% from price
RSI (14)
55.5
Neutral
MACD (12,26,9)
0.16
Hist 0.22
ATR (14)
1.27
3.47% of price
Realised vol 30D
31.8%
Annualised
Bollinger upper
37.47
20, 2σ
Bollinger lower
33.57
20, 2σ
50 / 200 cross
Death
35.88 vs 41.28
Trend bias
Below 200
-11.32%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.80
Less volatile than market
Correlation to SPY
0.19
Largely independent
Realised vol 30D
31.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-52.1%
Peak to trough
Max drawdown 5Y
-57.9%
Peak to trough
ATR 14
1.27
3.47% of price
Beta (reported)
0.42
5Y monthly, from filing
Short interest
Shares short
1.14M
Prior 1.23M
Change vs prior
-7.4%
Shorts covering
% of float
6.43%
Normal
% of shares out
2.81%
Against total outstanding
Days to cover
4.7
Liquid
Float
20.91M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 14, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Apr 15, 26 | Citigroup | INITIATED | — | Neutral |
| Nov 7, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 29, 25 | B of A Securities | MAINTAINED | Underperform | Underperform |
| Jul 7, 25 | JP Morgan | UPGRADE | Neutral | Overweight |
| Jun 25, 25 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| May 8, 25 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 10, 25 | Barclays | MAINTAINED | Underweight | Underweight |
| Dec 17, 24 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Nov 12, 24 | Barclays | MAINTAINED | Underweight | Underweight |
| Sep 10, 24 | JP Morgan | INITIATED | — | Neutral |
| Aug 30, 24 | B of A Securities | MAINTAINED | Underperform | Underperform |
Dividends & splits
Forward rate$0.48 / yr
Forward yield1.31%
5-year avg yield2.08%
Payout ratio19.75%
Ex-dividend dateSep 2, 2026
Next pay dateSep 23, 2026
Last split—
Split date—
SEC filings
Proxy Statements
DEF 14A · 2026-09-18
Corporate Changes & Voting Matters
8-K · 2026-08-26
Corporate Changes & Voting Matters
8-K · 2026-07-28
Corporate Changes & Voting Matters
8-K · 2026-06-26
Corporate Changes & Voting Matters
8-K · 2026-05-06
Corporate Changes & Voting Matters
8-K · 2026-05-05
Corporate Changes & Voting Matters
8-K · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-04-27
Headlines
PAHC vs. HAE: Which Stock Is the Better Value Option?
Zacks · 2d ago
Neogen Stock Rallies 83% YTD: What's Driving the Surge?
Zacks · 6d ago
Should You Continue to Hold IART Stock in Your Portfolio?
Zacks · 7d ago
Chewy's Vet Care Posts Triple-Digit Growth as Clinic Scale Builds
Zacks · 8d ago
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
Zacks · 8d ago
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Zacks · 9d ago
Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
Zacks · 12d ago
Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 13d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.